Product Development

Phase II learnings set up microbiome play Seres for Phase III success

New data keep Seres ahead of microbiome competition in C. difficile race

Improved diagnostic, higher dose set up Seres for Phase III success in C. difficile infection following SER-109’s Phase II miss in 2016. 

Seres parlayed lessons learned from